HS Code for Human Blood, Animal Blood, and Immunological Products
Navigating the global trade of high-value biological substances requires precision, compliance, and a deep understanding of international regulatory frameworks. When managing shipments under HS Code 3002, logistics professionals are not merely moving cargo; they are safeguarding life-saving materials, including human blood, animal blood, vaccines, and complex immunological products. As of 2026, the complexity of this sector has only increased, demanding that exporters and importers maintain rigorous standards for temperature control, hazardous material management, and customs documentation.
The classification of products under 3002—ranging from therapeutic antisera to advanced cell cultures—places them in a high-scrutiny category. Whether you are dealing with UN3373 biological substances or specialized frozen plasma, the ability to ensure end-to-end visibility is paramount. At FreightAmigo, we recognize that the stakes for these shipments are significantly higher than for general freight, as even a minor temperature excursion can compromise the entire shipment.
Key Benefits of Mastering HS Code 3002 Logistics
- Regulatory Compliance: Properly identifying your goods under the correct 3002 HSN code prevents customs delays and potential regulatory penalties.
- Risk Mitigation: Utilizing GDP-compliant logistics solutions ensures the integrity of temperature-sensitive biological products from origin to destination.
- Operational Efficiency: Leveraging digital tools for documentation and tracking reduces the administrative burden of handling complex, high-value medical cargo.
Understanding the landscape of this sector requires a look at the trade data. The global market for these products, while stabilizing after the post-pandemic vaccine surge, remains a multi-billion dollar cornerstone of international trade. Leading exporters such as Ireland, the United States, and Germany continue to dominate the biotech landscape, while emerging markets in Asia are increasingly becoming key players in the distribution of diagnostic and immunological products.
| Category | Risk Level | Typical UN Classification | Packaging Requirement |
|---|
| High Risk | Category A | UN2814/2900 | Triple packaging + specialized infectious labeling |
| Low Risk | Category B | UN3373 | Triple packaging (leakproof primary/secondary + absorbent) |
| Frozen Goods | Varies | UN1845 (Dry Ice) | Vented containers for dry ice sublimation |
For those managing these shipments, the primary challenge is the cold chain. Most products under HS Code 3002 are highly sensitive to thermal fluctuations. To navigate these challenges, we invite you to use our Instant Quote tool to compare specialized transport options that prioritize speed and environmental control. For complex shipments, integrating our Customs Clearance services ensures that your HS code classification is verified against the latest local and international trade requirements, reducing the risk of transit delays.
The Logistics of High-Value Biologicals
The transport of items classified under 3002 often demands an air-freight-first strategy. Given the time-sensitive nature of vaccines and blood fractions, over 95% of these goods move via air to ensure they arrive within the required temperature windows—whether those windows are 2-8°C for refrigerated vaccines or -70°C for advanced mRNA therapies. The industry relies heavily on IATA Dangerous Goods Regulations (DGR) to ensure safety during transit.
Beyond the physical transport, the administrative burden is significant. Every shipment requires clear documentation regarding the biological status of the contents. Failure to correctly declare whether a product is infectious or non-infectious, or mislabeling the temperature requirements, is a leading cause of cargo rejection at borders. As a freight professional, you must ensure that your logistics partners are trained in the handling of Division 6.2 infectious substances, as defined by IATA and the IMDG code for sea shipments.
Frequently Asked Questions
What does HS Code 3002 cover exactly?
HS Code 3002 covers human and animal blood prepared for therapeutic, prophylactic, or diagnostic uses, as well as antisera, vaccines, toxins, cultures of micro-organisms, and cell cultures.
Is there a difference between the 3002 HSN code in India and the global HS code?
The 3002 HSN code follows the international Harmonized System nomenclature at the 6-digit level, which is standard globally. National variations usually occur at the 8-digit or 10-digit level for specific tax or duty purposes.
How should I package vaccines classified under UN3373?
Vaccines classified as Category B (UN3373) must use triple packaging: a leakproof primary receptacle, a leakproof secondary packaging with sufficient absorbent material, and a rigid outer packaging.
What is the most common challenge in shipping biologicals?
The most significant challenge is maintaining the cold chain. Temperature excursions account for a large percentage of insurance claims and lost cargo in the biotech sector.
Do I need special permits for exporting immunological products?
Yes, depending on the destination country, you may require health certificates, import permits from local health authorities, and specific declarations for biological substances.
How does FreightAmigo help with these shipments?
We provide instant rate comparisons for specialized freight, AI-driven customs compliance support, and real-time tracking to ensure your high-value cargo remains secure throughout the entire journey.
Conclusion
Managing the logistics for goods under HS Code 3002 is an exercise in precision and responsibility. By focusing on compliant packaging, strict temperature management, and accurate customs documentation, you can ensure that these critical products reach their destination safely. If you are ready to streamline your shipping process, explore our range of services at FreightAmigo. From our Instant Quote calculator to our comprehensive Customs Clearance solutions, we are here to support your logistics operations with the technology and expertise required for success in 2026.